$BCRX Maggots “The smartest businessman I know” we all are in trouble.
BCRX
-0.45 (2.93%)
14.92
| General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Comparison | ||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||
Profile
...
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase I clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. BioCryst Pharmaceuticals, Inc. has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. The company was founded in 1986 and is headquartered in Durham, North Carolina.
Earning
...
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2021-11-04 | 2021-09 | -0.3 | N/A | N/A | N/A |
| 2021-08-05 | 2021-06 | -0.22 | -0.24 | -0.02 | -9.09% |
| 2021-05-06 | 2021-03 | -0.26 | -0.36 | -0.1 | -38.46% |
| 2021-02-25 | 2020-12 | -0.25 | -0.34 | -0.09 | -36.00% |
| 2020-11-05 | 2020-09 | -0.25 | -0.26 | -0.01 | -4.00% |
| 2020-08-06 | 2020-06 | -0.28 | -0.24 | 0.04 | 14.29% |
Upgrade / Downgrade
...
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2021-08-06 | Jefferies | Downgrade | Buy | Hold |
| 2021-08-06 | RBC Capital | Upgrade | Sector Perform | |
| 2021-08-06 | JMP Securities | Upgrade | Market Outperform | |
| 2021-08-06 | Barclays | Upgrade | Overweight | |
| 2021-08-06 | HC Wainwright & Co. | Upgrade | Buy | |
| 2021-08-03 | Cantor Fitzgerald | Upgrade | Overweight |
Insider Holder
...
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2021-09-14 | ABERCROMBIE GEORGE B | Director | 0.00 | Sale |
| 2021-08-30 | ASELAGE STEPHEN J | Director | 32.44K | Stock Award(Grant) |
| 2021-05-11 | BARNES ALANE P | Officer | 146.13K | Conversion of Exercise of derivative security |
| 2021-08-30 | HEGGIE THERESA | Director | 14.79K | Stock Award(Grant) |
| 2021-06-09 | HUTSON NANCY J | Director | 65.07K | Sale |
| 2021-08-30 | INGRAM ROBERT ALEXANDER | Director | 77.38K | Stock Award(Grant) |
Institution Ownership
...
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2021-06-29 | Blackrock Inc. | 15.48M | 244.76M | 8.66% |
| 2021-06-29 | Baker Brothers Advisors, LLC | 12.71M | 200.96M | 7.11% |
| 2021-06-29 | Vanguard Group, Inc. (The) | 9.30M | 147.10M | 5.20% |
| 2021-06-29 | State Street Corporation | 6.25M | 98.86M | 3.50% |
| 2021-06-29 | Sarissa Capital Management, LP | 4.26M | 67.37M | 2.38% |
| 2021-06-29 | Healthcor Management LP | 3.25M | 51.35M | 1.82% |
Fund Ownership
...
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2021-06-29 | Vanguard Total Stock Market Index Fund | 5.04M | 79.67M | 2.82% |
| 2021-07-30 | iShares Russell 2000 ETF | 4.01M | 64.66M | 2.24% |
| 2021-07-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.75M | 44.36M | 1.54% |
| 2021-06-29 | Vanguard Extended Market Index Fund | 2.55M | 40.27M | 1.42% |
| 2021-06-29 | Artisan International Small-Mid Fund | 2.14M | 33.81M | 1.20% |
| 2021-07-30 | iShares Russell 2000 Value ETF | 1.75M | 28.13M | 0.98% |
Dividend
...
| Dividend | Date |
|---|---|
| 0 | 2014-06-11 |
| 0 | 2014-06-05 |
| 0 | 2014-05-20 |
| 0 | 2014-05-16 |
| 0 | 2014-04-02 |
This topic has been deleted. Only users with topic management privileges can see it.
-
-
$BCRX I did a 250 add back on 8/10/21 @ 16.54 and it’s in the rear view mirror we are all on the ride of a life time!
-
$BCRX @Sil I got the same problem I bought 20,000 shares back on 3/18/20 @$1.66 / share sorry for your loss just hold it’ll work out in the looooong run.
-
$BCRX 🤙
-
$BCRX OPPS wrong plate poor reading comprehension
-
$BCRX Follow that car👮🏼♂️🚓
-
$BCRX We’ve gota close above 14.47 today
-
$BCRX Thanks for the last several positive posts all I know is BUY HOLD AND GET RICH any dought move out !
-
$BCRX Ryan you need to go back to the hole you live in your a sick puppy
-
$BCRX Thanks Brian
-
$BCRX So now we have a retired bologna machine salesman summing up BCRX for us Mr Mcnew
-
9160 shares started buying at $6.86 not a ton compared to people on here but I add as much I can without going in here 100% which I often think about doing.
-
$BCRX Oh well $14.75 here we come hold on trigger
-
$BCRX Got any buyers for 500 shares of CVM I need more BCRX
-
$BCRX Man Tony I’m gonna duplicate that tonight. I’ll be thinking about it all day along with one other thing that starts with a B.
-
$BCRX The sleeping GIANT
-
$BCRX Anyone got any cash they don’t need for a few yrs?
-
$BCRX In memory of my friend Pewee (5’3”) who was a member of the 6000 Airborne Screaming Eagles that parachuted in behind German lines June 6 1944 to provide intelligence for D Day invasion June 7 1944. We all should be so brave and yet many of us including or President try to tear down our country. WHY? Because we let them!
-
$BCRX Except for Joe Biden what a disgusting and incompetent individual